Edition:
United Kingdom

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

1.83USD
3:49pm GMT
Change (% chg)

$0.08 (+4.57%)
Prev Close
$1.75
Open
$1.77
Day's High
$1.89
Day's Low
$1.77
Volume
3,351
Avg. Vol
33,334
52-wk High
$4.56
52-wk Low
$1.49

Chart for

About

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the... (more)
No analyst recommendations are available for .

Overall

Beta: 0.85
Market Cap(Mil.): $200.04
Shares Outstanding(Mil.): 52.37
Dividend: --
Yield (%): --

Financials

  NYMX.OQ Industry Sector
P/E (TTM): -- 83.62 33.60
EPS (TTM): -0.23 -- --
ROI: -- -0.65 15.05
ROE: -- 0.07 16.62

Earnings vs. Estimates